简体中文
繁體中文
English
Pусский
日本語
ภาษาไทย
Tiếng Việt
Bahasa Indonesia
Español
हिन्दी
Filippiiniläinen
Français
Deutsch
Português
Türkçe
한국어
العربية
Abstract:Aug 4 (Reuters) - U.S.-based private equity fund Blackstone (BX.N) will submit a bid next week to ac
Aug 4 (Reuters) - U.S.-based private equity fund Blackstone (BX.N) will submit a bid next week to acquire a 33.47% stake in Indian drugmaker Cipla (CIPL.NS), the Economic Times reported on Friday, citing sources.
The stake sale will formally start the exit of the Hamied family who had founded Cipla in 1935, the report added.
Cipla and Blackstone did not immediately respond to Reuters request for comment.
The move will also trigger an open offer for an additional 26% of Cipla, upon full subscription of which Blackstone would end up owning as much as 59.4% of Ciplas stake, according to the report.
Last Month, Moneycontrol had reported that top shareholders of the pharma major, which includes Blackstone are in talks to sell a part of their stake to private equity players.
Shares of the company have risen over 14% since the Moneycontrol report, and hit record high on Friday.
Disclaimer:
The views in this article only represent the author's personal views, and do not constitute investment advice on this platform. This platform does not guarantee the accuracy, completeness and timeliness of the information in the article, and will not be liable for any loss caused by the use of or reliance on the information in the article.